0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology

Buy Now

Interleukin Protocols (Paperback, Softcover reprint of hardcover 1st ed. 2001) Loot Price: R3,018
Discovery Miles 30 180
Interleukin Protocols (Paperback, Softcover reprint of hardcover 1st ed. 2001): Luke A.J. O'Neill, Andrew Bowie

Interleukin Protocols (Paperback, Softcover reprint of hardcover 1st ed. 2001)

Luke A.J. O'Neill, Andrew Bowie

Series: Methods in Molecular Medicine, 60

 (sign in to rate)
Loot Price R3,018 Discovery Miles 30 180 | Repayment Terms: R283 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Interleukins are a family of proteins that regulate the maturation, diff- entiation, or activation of cells involved in immunity and inflammation, and belong to a broader family termed cytokines. Collectively these proteins are the key orchestrators of host defense and the response to tissue injury. There are currently 23 different interleukins (numbered from IL-1 to IL-23), although the full extent of the interleukin family will only become clear upon analysis of the human genome sequence. Most important, interleukins are central to the pathogenesis of a wide range of diseases that involve an immune com- nent, including such conditions as rheumatoid arthritis, multiple sclerosis, ulcerative colitis, psoriasis, and asthma. Interleukins have also been imp- cated in other conditions, including cancer, migraine, myocardial infarction, and depression. In essence, when cells are activated by interleukins, a program of gene expression is initiated in the target cell that alters the cell's phenotype, leading to enhanced immune reactivity, inflammation, and/or proliferation. Interleukins are therefore at the core of the cellular basis for many diseases. They are the subject of intense investigation by biomedical researchers and the targeting or use of interleukins in the clinic is proceeding apace. Approaches such as t- geting IL-4 in asthma or IL-1 in joint disease are being pursued, and it is likely that in the next 5-10 years a number of new therapies based on either inhib- ing or administering interleukins will be available.

General

Imprint: HumanaPress
Country of origin: United States
Series: Methods in Molecular Medicine, 60
Release date: October 2010
First published: 2001
Editors: Luke A.J. O'Neill • Andrew Bowie
Dimensions: 229 x 152 x 26mm (L x W x T)
Format: Paperback
Pages: 443
Edition: Softcover reprint of hardcover 1st ed. 2001
ISBN-13: 978-1-61737-162-2
Categories: Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology > General
LSN: 1-61737-162-9
Barcode: 9781617371622

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners